To Stimulate or Withdraw? A Cost-Utility Analysis of Recombinant Human ThyrotropinVersusThyroxine Withdrawal for Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer in the United States
2010 ◽
Vol 95
(4)
◽
pp. 1672-1680
◽
Keyword(s):
2019 ◽
Vol 45
(7)
◽
pp. 927-938
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):